BioNexus Gene Lab Corp - BGLC
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DRW Securities, LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -47,830 | -100.0% | Q1 2026 | May 13, 2026 |
| UBS Group AG | History | New | 231 | 0 | — | — | — | +231 | New | Q1 2026 | May 05, 2026 |
| WELLS FARGO & COMPANY/MN | History | New | 1 | 0 | — | — | — | +1 | New | Q1 2026 | May 11, 2026 |